展示99.1

ハーバライフ 第3四半期2024年の業績を報告

売上高は期待に添っており、調整後のEBITDAは¹ ガイダンスを上回りました；
年間調整後のEBITDA予想を引き上げました¹ 指導

ロサンゼルス2024年10月30日、ハーバライフ(ハーバライフ)は、2024年9月30日に終了した第3四半期の財務結果を発表しました：

ハイライト

2024年第3四半期

見通し

¹ 非GAAP尺度。歴史的期間について、これらの尺度を最も直接的な米国GAAP尺度に詳細に調整するためのスケジュールA-「非GAAP財務尺度の調整」を参照し、必要に応じて、およびなぜ企業がこれらの非GAAP尺度が有用であると信じているか、および非GAAPガイダンスに関する一定の情報についての議論が含まれています。

² 外国為替の影響を除いた純売上高の増減は、「現地通貨での純売上高」に基づくものであり、これは非GAAP財務指標です。「外国為替の影響を調整することが有用である」と会社が考える理由については、非GAAP財務指標の調整に関するスケジュールAを参照してください。

経営者解説

ハーバライフは、2024年第3四半期の純売上高が12億ドルで、前年比3.2％減少し、290ベーシスポイントの外国為替の逆風を含んでいます。 通貨ベースでは²純売上高は前年比0.3％減少しました。

2023年第3四半期の粗利益率は76.3%から78.3%に改善しました。年間ベースで、粗利益率は主に価格上昇の約110ベーシスポイントと製造効率の向上や原材料費の低下による110ベーシスポイントの恩恵を受けましたが、販売ミックスの約30ベーシスポイントの不利が部分的に相殺されました。

純利益 は4,740万ドルで、純利益率は 3.8%、調整後純利益は¹ 5,800万ドルです。調整後EBITDAです¹ の 1億6,650万ドルには、調整後EBITDAを含めて、前年比で約1,400万ドルの外貨の逆風が含まれています¹ マージン 13.4％で、前年比70ベーシスポイント上昇しました。希薄化後EPSは0.46ドル、調整後の希薄化後EPSを含めて¹ 0.57ドルです。これには 前年比0.10ドルという外貨の逆風。

営業活動による純現金は2024年9月30日までの3か月と9か月間でそれぞれ9950万ドルと21580万ドルでした。資本支出はそれぞれ2024年9月30日までの3か月と9か月で約2700万ドルと9600万ドルであり、キャピタライズされたsaas導入コストはそれぞれ約300万ドルと1300万ドルでした。会社は2024年の通期に約12000万ドルから14000万ドル（12000万ドルから15000万ドルに減額）の総資本支出と約2000万ドル（約2000万ドルから2500万ドルに減額）の総キャピタライズされたSaaS導入コストを見込んでいます。

2024年第1四半期に、企業はリーダーシップを市場に近づけ、従業員構造を簡素化し、生産性を加速させるための再編プログラムを開始しました。プログラムに関連するほぼ全ての措置は6月30日までに完了し、残りは2024年末までに完了する予定です。再編プログラムは2025年から少なくとも8000万ドルの年間節約をもたらすことが期待されており、2024年には少なくとも5000万ドルの節約が見込まれています。2024年9月30日までの措置に基づくと、2024年9月30日までの3か月および9か月間で、それぞれ少なくとも2000万ドルと少なくとも3000万ドルの節約が実現されました。企業は2024年に、プログラムに関連する約7000万ドルの総事前税費用を見込んでおり、これらは主に解雇費用に関連するものであり、調整後の結果から除外されます。2024年9月30日までの3か月および9か月間で、それぞれ約300万ドルと6800万ドルの事前税費用が、再編に関連するSG&Aで認識されました。

7月、会社はカリフォルニア州トーランスのオフィスビルを売却し、16か月のリースバック取引を完了しました。短期のリース契約により、南カリフォルニアの他のオフィスに従業員を移転する十分な時間が確保されます。売却取引の純利益は約3800万ドルでした。会社は2024年第3四半期のSG&Aに関連する売却に関連する約400万ドルの税引前利益を認識しましたが、これは調整後の結果から除外されています。

「当社の利益率は前年同期比で改善され、財務基盤を強化し続けています」と、チーフ・ファイナンシャル・オフィサーのジョン・デシモーネは述べました。「当四半期において負債を減らしました。9月30日時点で総レバレッジ比率は3.3倍に下がり、2025年末までに総レバレッジ比率を3.0倍に引き下げる予定であり、さらに次の4〜5年で総負債を10億ドル減額する見通しです。」

2024年第三四半期に、ハーバライフへの新しい販売代理店の数は世界中で前年同期比14%増加し、前年同期比改善の続いている二つ目の四半期を示しました。販売代理店の関与は強く、強化されたトレーニングの機会やコミュニティ構築イニシアティブがあります。

8月、会社は米国で新しく全く新しいDiamond Development Mastermind Programを開始しました。President Stephan Gratziani率いる継続的なトレーニングおよび責任プログラムで、ネットワークマーケティング業種のリーダーやコーチであるEric Worreの支援を受けています。約800人の販売店リーダーが参加し、Gratziani氏のハーバライフの独立販売店としての以前の経験と、Worre氏のダイレクトセリングビジネスに関する豊富な知識を活用した実践的指導を受けました。提示された内容には、彼らのハーバライフ ビジネスをさらに最適化しスケールさせるためのコアビジネス原則、組織の発展をサポートするリーダーシップコンセプト、販売店のパフォーマンスメトリクスを分析し、潜在的な新しいビジネス機会を特定するための主要な口座管理モデルの導入が含まれています。

Extravaganza training events also continued in September and October. Approximately 37,300 attendees convened at events in Mexico, the UK and Uzbekistan to learn best practices, trends and new business insights. The Mexico event was highly anticipated among attendees and sold out in five weeks, three and a half months in advance of the training. A virtual attendance option was later added to accommodate the demand. To date, the Company’s 2024 Extravaganza training events have attracted approximately 134,600 attendees.

On September 21, independent distributors, fitness enthusiasts and employees participated in the Herbalife 2024 Worldwide Workout, demonstrating their unique ability to activate their communities through a healthy active lifestyle. During the event, the Company set a new GUINNESS WORLD RECORDS™ title for the Largest High-Intensity Interval Training Class across multiple venues. Over 4,900 individuals took part in workouts at host sites in Las Vegas, Nevada, Los Angeles, California, Mexico City, Mexico and Mumbai, India, among others. More than 11,000 participants from all over the world also joined the workout virtually via Herbalife’s YouTube livestream.

“We see a new and exciting energy all across Herbalife,” said Michael Johnson. “We are providing opportunities for our distributors to enhance their skills and create a community for their customers through good nutrition and health and wellness. In our 44 years as a company, our impact continues to stand on its own merit.”

Regional Net Sales and Foreign Exchange (“FX”) Impact

Regional Volume Point Metrics

Note: During Q2 ‘24, most markets within the Latin America region, excluding Mexico, implemented a 5% price reduction and Volume Point adjustments to enhance the competitiveness of product pricing, aiming to stimulate incremental volume growth and increase Members’ ability to promote business opportunities. Refer to the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024, for additional details.

Fourth Quarter 2024 Guidance

Full-Year 2024 Guidance – Revised

Herbalife’s senior management team will host a live audio webcast and conference call to discuss its third quarter 2024 financial results on Wednesday, October 30, 2024, at 5:30 p.m. ET (2:30 p.m. PT).

The live audio webcast will be available at the following link: https://edge.media-server.com/mmc/p/i5tx7naj.

Participants joining via the conference call may obtain the dial-in information and personal PIN to access the call by registering at the following link: https://register.vevent.com/register/BIe4627c57c8fd4c99b8cda37657987d7c.

Senior management also plans to reference slides during the webcast and call, which will be available under the Investor Relations section of Herbalife’s website at https://ir.herbalife.com, where financial and other information is posted from time to time. The live webcast will also be available at the same website, along with a replay of the webcast following the completion of the event and for 12 months thereafter.

Herbalife (NYSE: HLF) is a premier health and wellness company, community and platform that has been changing people's lives with great nutrition products and a business opportunity for its independent distributors since 1980. The Company offers science-backed products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life.

For more information, visit https://ir.herbalife.com.

Forward-Looking Statements

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management, including for future operations, capital expenditures, or share repurchases; any statements concerning proposed new products, services, or developments; any statements regarding future economic conditions or performance; any statements of belief or expectation; and any statements of assumptions underlying any of the foregoing or other future events. Forward-looking statements may include, among others, the words “may,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect,” “anticipate” or any other similar words.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results or outcomes could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include the following:

Additional factors and uncertainties that could cause actual results or outcomes to differ materially from our forward-looking statements are set forth in the Company's Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2024, filed with the Securities and Exchange Commission on October 30, 2024, including under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in our Condensed Consolidated Financial Statements and the related Notes included therein, and Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the Securities and Exchange Commission on February 14, 2024, including under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in our Consolidated Financial Statements and the related Notes included therein. In addition, historical, current, and forward-looking sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future.

Forward-looking statements made in this release speak only as of the date hereof. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

Supplemental Information

SCHEDULE A: RECONCILIATION OF NON-GAAP FINANCIAL MEASURES (unaudited)

Adjusted Net Income, Adjusted Diluted EPS, Adjusted EBITDA and Credit Agreement EBITDA

In addition to its reported results calculated in accordance with U.S. GAAP, the Company has included in this release adjusted net income, adjusted diluted EPS, adjusted EBITDA and credit agreement EBITDA, performance measures that the Securities and Exchange Commission defines as “non-GAAP financial measures.” Adjusted net income, adjusted diluted EPS, adjusted EBITDA and credit agreement EBITDA exclude the impact of certain unusual or non-recurring items such as expenses related to restructuring initiatives, expenses related to the digital technology program, gains or losses from sale of property, gains or losses from extinguishment of debt and Korea tax settlement, as further detailed in the reconciliations below. Adjusted EBITDA margin represents adjusted EBITDA divided by net sales. Credit agreement EBITDA represents EBITDA adjusted for items permitted under our senior secured credit facilities.

Management believes that such non-GAAP performance measures, when read in conjunction with the Company’s reported results, calculated in accordance with U.S. GAAP, can provide useful supplemental information for investors because they facilitate a period to period comparative assessment of the Company’s operating performance relative to its performance based on reported results under U.S. GAAP, while isolating the effects of some items that vary from period to period without any correlation to core operating performance and eliminate certain charges that management believes do not reflect the Company’s operations and underlying operational performance.

The Company’s definitions and calculations as set forth in the tables below of adjusted net income, adjusted diluted EPS, adjusted EBITDA and credit agreement EBITDA may not be comparable to similarly titled measures used by other companies because other companies may not calculate them in the same manner as the Company does and should not be viewed in isolation from, nor as alternatives to, net income or diluted EPS calculated in accordance with U.S. GAAP.

The Company does not provide a reconciliation of forward-looking adjusted EBITDA guidance to net income, the comparable U.S. GAAP measure, because, due to the unpredictable or unknown nature of certain significant items, such as income tax expenses or benefits, loss contingencies, and any gains or losses in connection with refinancing transactions, we cannot reconcile this non-GAAP projection without unreasonable efforts. We expect the variability of these items, which are necessary for a presentation of the reconciliation, could have a significant impact on our reported U.S. GAAP financial results.

Currency Fluctuation

Our international operations have provided and will continue to provide a significant portion of our total net sales. As a result, total net sales will continue to be affected by fluctuations in the U.S. dollar against foreign currencies. In order to provide a framework for assessing how our underlying businesses performed excluding the effect of foreign currency fluctuations, in addition to comparing the percent change in net sales from one period to another in U.S. dollars, we also compare the percent change in net sales from one period to another period using “net sales in local currency.” Net sales in local currency is not a measure presented in accordance with U.S. GAAP. Net sales in local currency removes from net sales in U.S. dollars the impact of changes in exchange rates between the U.S. dollar and the local currencies of our foreign subsidiaries, by translating the current period net sales into U.S. dollars using the same foreign currency exchange rates that were used to translate the net sales for the previous comparable period. We believe presenting net sales in local currency is useful to investors because it allows a meaningful comparison of net sales of our foreign operations from period to period. However, net sales in local currency should not be considered in isolation or as an alternative to net sales in U.S. dollar measures that reflect current period exchange rates, or to other financial measures calculated and presented in accordance with U.S. GAAP.

The following is a reconciliation of net income to adjusted net income:

The following is a reconciliation of diluted earnings per share to adjusted diluted earnings per share:

The following is a reconciliation of net income to EBITDA, adjusted EBITDA and Credit Agreement EBITDA and Credit Agreement total leverage ratio:

The following is a reconciliation of net income to EBITDA, adjusted EBITDA and Credit Agreement EBITDA and Credit Agreement total leverage ratio:

(1) Based on interim income tax reporting rules, these (income)/expense items are not considered discrete items. The tax effect of the adjustments between our U.S. GAAP and non-GAAP results takes into account the tax treatment and related tax rate(s) that apply to each adjustment in the applicable tax jurisdiction(s).

(2) Excludes tax (benefit)/expense as follows:

(3) Other expenses include certain non-cash items such as bad debt expense, unrealized foreign currency gains and losses, and other gains and losses

(4) Represents the outstanding principal amount of total debt as of the respective period end

(5) Amounts may not total due to rounding